Search Results - "Misawa, Sonoko"

Daratumumab (anti-CD38)- and elotuzumab (anti-SLAMF7)-based treatments for refractory POEMS syndrome: a single-center case series.

Authors: Suichi, Tomoki Misawa, Sonoko Shibuya, Kazumoto et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-8. 8p.

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).

Authors: Misawa, Sonoko Denda, Tadamichi Kodama, Sho et al.

Source: BMC Cancer. 11/11/2023, Vol. 23 Issue 1, p1-11. 11p.

Blood–Nerve Barrier Breakdown Induced by Immunoglobulin G in Typical and Multifocal Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy.

Authors: Shimizu, Fumitaka Sato, Ryota Mizukami, Yoichi et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p1088. 13p.

A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.

Authors: Shibuya, Kazumoto Misawa, Sonoko Kimura, Hideki et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Sep2015, Vol. 16 Issue 5/6, p353-358. 6p.

Impaired neuromuscular transmission in facial muscles of amyotrophic lateral sclerosis: A single‐fiber electromyography study.

Authors: Watanabe, Keisuke Shibuya, Kazumoto Misawa, Sonoko et al.

Source: Neurology & Clinical Neuroscience. Mar2022, Vol. 10 Issue 2, p78-82. 5p.

Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome.

Authors: Iwase, Takehito Yokouchi, Hirotaka Misawa, Sonoko et al.

Source: Neuro-Ophthalmology. Feb2018, Vol. 42 Issue 1, p25-30. 6p.

Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study.

Authors: Suzuki, Yo-ichi Shibuya, Kazumoto Misawa, Sonoko et al.

Source: BMC Neurology. 3/11/2022, Vol. 22 Issue 1, p1-7. 7p.

Diagnostic utility of Gold Coast criteria for amyotrophic lateral sclerosis in Asia.

Authors: Otani, Ryo Shibuya, Kazumoto Shimizu, Toshio et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. May2024, Vol. 25 Issue 3/4, p264-270. 7p.

Decreased initial compound muscle action potential amplitudes in myasthenia gravis.

Authors: Kojima, Yuta Shibuya, Kazumoto Uzawa, Akiyuki et al.

Source: Neurology & Clinical Neuroscience. Sep2022, Vol. 10 Issue 5, p245-251. 7p.

POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification.

Authors: Araki, Nobuyuki Misawa, Sonoko Shibuya, Kazumoto et al.

Source: Orphanet Journal of Rare Diseases. 4/12/2016, Vol. 11, p1-7. 7p.

Efficacy and safety of eculizumab in Guillain‐Barré syndrome: A phase 3, multicenter, double‐blind, randomized, placebo‐controlled clinical trial.

Authors: Kuwabara, Satoshi Kusunoki, Susumu Kuwahara, Motoi et al.

Source: Journal of the Peripheral Nervous System. Sep2024, Vol. 29 Issue 3, p339-349. 11p.

Development of new treatments with drug repositioning strategies: POEMS and Guillain‐Barré syndrome.

Authors: Misawa, Sonoko¹ (AUTHOR) sonoko.m@nifty.com

Source: Neurology & Clinical Neuroscience. Jan2021, Vol. 9 Issue 1, p50-55. 6p.

Changes in nerve excitability indices in hereditary transthyretin amyloidosis.

Authors: Yamashita, Taro Ueda, Mitsuharu Misawa, Sonoko et al.

Source: Amyloid. 2019 Supplement 1, Vol. 26, p9-10. 2p.

Guillain‐Barré syndrome: Novel treatment by complement inhibition.

Authors: Misawa, Sonoko Suichi, Tomoki

Source: Clinical & Experimental Neuroimmunology. May2020, Vol. 11 Issue 2, p90-93. 4p.

Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: Diagnosis, treatment and the current status in Japan.

Authors: Suichi, Tomoki Misawa, Sonoko

Source: Clinical & Experimental Neuroimmunology. May2020, Vol. 11 Issue 2, p101-108. 8p.

Cerebral large artery stenosis and occlusion in POEMS syndrome.

Authors: Sugiyama, Atsuhiko Yokota, Hajime Misawa, Sonoko et al.

Source: BMC Neurology. 6/24/2021, Vol. 21 Issue 1, p1-9. 9p.

Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi‐center, open‐label, 52‐week phase 3 trial.

Authors: Kuwabara, Satoshi Misawa, Sonoko Mori, Masahiro et al.

Source: Journal of the Peripheral Nervous System. Jun2018, Vol. 23 Issue 2, p115-119. 5p.

Future treatment for Guillain-Barré syndrome.

Authors: Kuwabara, Satoshi Misawa, Sonoko

Source: Clinical & Experimental Neuroimmunology. Nov2016, Vol. 7 Issue 4, p320-323. 4p.

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value.

Authors: Noto, Yu-Ichi Shibuya, Kazumoto Sato, Yasunori et al.

Source: Amyotrophic Lateral Sclerosis. Mar2011, Vol. 12 Issue 2, p140-143. 4p. 1 Chart, 2 Graphs.

Combined nerve/muscle/skin biopsy could increase diagnostic sensitivity for vasculitic neuropathy.

Authors: Masuda, Hiroki Misawa, Sonoko Arai, Kimihito et al.

Source: Clinical & Experimental Neuroimmunology. Aug2015, Vol. 6 Issue 3, p312-317. 6p.